7:45 - 8:45 a.m. |
Breakfast & Industry Symposium |
9:00 - 10:00 a.m. |
SIO Meets SITC: Beyond Liver (300 Level Education)
Moderated by Rony Avritscher, MD, and Tulia C. Bruno, PhD
- IO's Role in the Development and Application of Antitumoral Vaccines
- Immunoscoring and TLCs as a Biomarker of Response to Local Therapy
- Biomechanical Issues in Intratumoral Interventions
- Lessons Learned from Melanoma to RCC Therapy?
- IO Approaches to Overcoming Barriers in CAR-T Cell Delivery

|
10:15 - 11:15 a.m. |
OMD Tumor Board [Non-Hepatic] (200 Level Education)
Moderated by Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, and David Breen, MD, FRCR
- Alda Tam, MD
- Robert Liddell, MD
- Alexandra Hotca-Cho, MD
- Dimitrios Filippiadis, MD, PhD, MSc, EBIR
- Michael Rutenberg, MD, PhD
|
Emerging Non-Thermal Ablation: Clinical Applications (300 Level Education)
Moderated by Paul Laeseke, MD, PhD, and Marwan Moussa, MD
- Limitations of Thermal Ablation, presented by Erica Knavel Koepsel, MD
- IRE: Role in the Liver, presented by Man-Deuk Kim, MD, PhD, FSIR
- Current Status, Data, and Limitations of Histotripsy, presented by Mishal Mendiratta-Lala, MD
- Electrochemotherapy in Palliation, presented by Frederic Deschamps, MD
- PEF in Advanced Lung Cancer: Where are We? presented by William Moore, MD
|
11:30 a.m. - 12:30 p.m. |
Scientific Oral Abstracts (200 Level Education)
|
Locally Advanced Pancreatic Cancer: Adding the Local Approach (300 Level Education)
Presented by William Rilling, MD, FSIR, and Govindarajan Narayanan, MD
- State of the Art Optimal Chemotherapy [mFolfirinox / Gem-nabPac] and Radiotherapy Consolidation presented by Michael J. Overman, MD
- Understanding the Difficult TME of LAPC, presented by Nadine Abi-Jaoudeh, MD
- IRE, Panfire-2 and Crossfire: What Have We Learned? presented by Hester J. Scheffer, MD
- Emerging Locoregional Technologies and Energies, presented by Martijn R. Meijerink, MD, PhD, FCIRSE
- Adjunctive Intra-arterial Approaches, presented by Paula Novelli, MD, FSIR
|
12:30 - 12:45 p.m. |
Industry Product Theater
|
12:45 - 1:45 p.m. |
Exhibit Hall & Lunch Symposium |
1:45 - 2:00 p.m. |
Industry Product Theater |
2:00 - 3:00 p.m. |
Discovery Theatre - Abstract Presentations |
3:00 - 4:30 p.m. |
Metastatic Liver Session: mCRC and mNET (200 Level Education)
Moderated by Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE
- mNET: Current Role of y90? presented by Ghassan El-Haddad, MD
- mNET: LDT for Grade 3 Disease, presented by Nicholas Fidelman, MD
- Assessment of FLR Function: How? presented by David C. Madoff, MD
- Optimal Strategies for Venous Deprivation? presented by Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE
- In Light of COLLISION: Optimal Approach to Bilobar Disease - IR Perspective, presented by Martijn R. Meijerink, MD, PhD, FCIRSE
- In Light of COLLISION: Optimal Approach to Bilobar Disease - Surgeons Perspective Cases, presented by Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE
|
Metastatic Bone and Soft Tissue Malignancy: Navigating the Multidisciplinary Landscape (200 Level Education)
Moderated by Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, and Steven Yevich, MD, MPH
- Critical Role of Surgical Oncology, presented by Matthew Goodwin, MD, PhD
- State of the Art Palliative Radiation and SBRT, presented byClifford G. Robinson, MD
- IR Role in the Multidisciplinary Treatment, presented by Matthew R. Callstrom, MD, PhD
- Multidisciplinary Tumor Board, moderated by Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, and Steven Yevich, MD, MPH, with Matt Goodwin, MD, PhD, Clifford G. Robinson, MD, and Matthew R. Callstrom, MD, PhD
|
7:00 - 10:00 p.m. |
Saturday Soiree Social Event*
Additional registration required
|